Kazia Therapeutics (KZIA) Income from Non-Controlling Interests (2009 - 2016)

Kazia Therapeutics (KZIA) has 4 years of Income from Non-Controlling Interests data on file, last reported at $69764.7 in Q4 2016.

• Quarterly Income from Non-Controlling Interests fell 41.95% year-over-year to $69764.7 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $345792.8 (down 100.0% YoY) and the FY2016 annual result came in at -$69964.5, up 45.76% from the prior year.
• Income from Non-Controlling Interests held at $69764.7 in Q4 2016, from $69443.3 in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of $14.6 billion in Q4 2013 to a low of $69443.3 in Q2 2016.
• A 4-year average of $2.9 billion and a median of $86396.5 in 2014 frame the typical range for Income from Non-Controlling Interests.
• Annual changes were most pronounced in 2014 — Income from Non-Controlling Interests plunged 100.0% — and 2015, when it jumped 39.11%.
• Tracing KZIA's Income from Non-Controlling Interests over 4 years: stood at $14.6 billion in 2013, then sank by 100.0% to $86396.5 in 2014, then jumped by 39.11% to $120188.3 in 2015, then slumped by 41.95% to $69764.7 in 2016.
• The last three Income from Non-Controlling Interests figures came in at $69764.7 (Q4 2016), $69443.3 (Q2 2016), and $120188.3 (Q4 2015), per Business Quant data.